
Share on:
Carlyle Group has hired investment bank Natixis to explore a sale of its stake in French medical equipment company Groupe Marle.
Marle specializes in orthopaedic implants, made from both alloys and polyethylene, and sells its products worldwide. The company is reported to produce one million implants annually and recorded €85MM (~US $97MM) in revenue for 2015.
Carlyle Group bought an 80% interest in Marle in 2009. The Marle family and management team retained a 20% stake.
Source: Wall Street Journal Â
In October 2015, Marle announced the acquisition of Finortho SAS, a company that specializes in polishing and sintering for rapid prototyping. Finortho was officially incorporated into Marle in January 2016 and became Marle Finishing SAS.
RELATED ARTICLES
Carpenter Technology’s Proposed Cobalt-free Alternative to CoCrMo Alloys for Articulating Orthopedic Implants
Oct 02 2025 , Carpenter Technology
Croom Medical Introduces Biofuse 3D-Printed Lattice Technology
Sep 16 2025 , Julie A. Vetalice
EXALTA is the New Brand Unifying Intech, Tyber and Resolve
Sep 10 2025 , Julie A. Vetalice